Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa

Authors :: Pillay, D.
Goodall, R.
Gilks, Cf
Yirrell, D.
Gibb, D.
Spyer, M.
Kaleebu, P.
Munderi, P.
Kityo, C.
Mccormick, A.
Nkalubo, J.
Lyagoba, F.
Chirara, M.
Hakim, J.
Source :: Journal of the International AIDS Society. November, 2010, Vol. 13, p20, 1 p.
Publication Year :: 2010
Abstract: 7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK<br />Background The SARA trial recently demonstrated a non‐inferior CD4 response, over median follow‐up of 60 weeks, with a boosted protease inhibitor monotherapy (bPImono) maintenance second‐line regimen compared with continuous combination [...]

Subjects :: Protease inhibitors -- Dosage and administration -- Testing
Drug therapy, Combination -- Dosage and administration -- Testing
CD4 lymphocytes -- Physiological aspects
HIV infection -- Care and treatment -- Drug therapy
Health

Full Text Access

Tools